# Tasso, Inc.

> Tasso is a Seattle medical device company that makes upper-arm capillary blood collection devices and coordinates kits, shipping and sample tracking for healthcare providers, laboratories, pharmaceutical companies and researchers. Its single-use devices support liquid and dried blood collection outside conventional blood-draw settings.

- **Founded:** 2012
- **Headquarters:** Seattle, United States
- **Founders:** Ben Casavant (Co-founder and CEO), Erwin Berthier (Co-founder and CTO), Ben Moga (Early co-founder and former president; identified in UW–Madison’s 2015 reporting)
- **Products:** Tasso+, Tasso Mini, Tile-T20, Tasso Solutions and Tasso Connect
- **Notable:** Tasso+ and Tasso Mini are FDA 510(k)-cleared Class II lancets., Two million devices sold, reported October 16, 2025., Customers in more than 60 countries and all 50 U.S. states, reported April 2026.

## Products & services

- **Tasso+** — FDA 510(k)-cleared Class II lancet for collecting liquid whole capillary blood into compatible collection tubes.
- **Tasso Mini** — FDA 510(k)-cleared Class II lancet for whole blood collection, positioned for frequent sampling and sensitive populations; compatible with selected tubes and dried blood cartridges.
- **Tile-T20** — Dried capillary blood cartridge collecting four volumetrically controlled 17.5 microliter samples; introduced with Tasso Mini for clinical trials and anti-doping.
- **Tasso Solutions and Tasso Connect** — Collection kit logistics, sample shipment coordination, digital tracking portal and API integration for organizational testing programs.

## Achievements

- Tasso+ and Tasso Mini are FDA 510(k)-cleared Class II lancets.
- Two million devices sold, reported October 16, 2025.
- Customers in more than 60 countries and all 50 U.S. states, reported April 2026.
- TS Blood Collection Kit received controlled medical device certification in Japan in September 2025.
- Co-founders received UW–Madison engineering Early Career Awards in 2024.

## Latest updates

- **2026-04** — Ben Casavant named an EY Entrepreneur Of The Year Mountain West finalist; Tasso reported customer reach exceeding 60 countries.
- **2026-03** — PD GENEration exceeded 30,000 enrolled participants; nearly half of its more than 900 monthly new participants used Tasso at-home blood collection.
- **2026-03** — Announced renewal of SOC 2 Type 2 compliance following an independent audit.
- **2026-02** — Tasso and InnoVero announced selection to supply anti-doping collection solutions for the 2026 Olympic Winter Games.
- **2025-10** — Reported two million devices sold.

## Links

- Website: https://www.tassoinc.com
- LinkedIn: https://www.linkedin.com/company/tasso-inc-/
- Twitter/X: https://twitter.com/tassoinc
- Facebook: https://facebook.com/teamtasso/

---

Profile page: https://yespress.io/tasso-inc
Published by YesPress — https://yespress.io
Last updated: 2026-10-15